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Objective/Background: We examined the rates, predictors, and outcomes [mortality
risk (MR), length of stay (LOS), and total charges (TC)] of sleep disturbances in older
hospitalized patients.
Patients/Methods: Using the U.S. Nationwide Inpatient Sample database
(2002–2012), older patients (≥60 years) were selected and rates of insomnia,
obstructive sleep apnea (OSA) and other sleep disturbances (OSD) were estimated
using ICD-9CM. TC, adjusted for inflation, was of primary interest, while MR and LOS
were secondary outcomes. Multivariable regression analyses were conducted.
Results: Of 35,258,031 older adults, 263,865 (0.75%) had insomnia, 750,851 (2.13%)
OSA and 21,814 (0.06%) OSD. Insomnia rates increased significantly (0.27% in 2002
to 1.29 in 2012, P-trend < 0.001), with a similar trend observed for OSA (1.47 in 2006
to 5.01 in 2012, P-trend < 0.001). TC (2012 $) for insomnia-related hospital admission
increased over time from $22,250 in 2002 to $31,527 in 2012, and increased similarly for
OSA and OSD; while LOS and MR both decreased. Women with any sleep disturbance
had lower MR and TC than men, while Whites had consistently higher odds of insomnia,
OSA, and OSD than older Blacks and Hispanics. Co-morbidities such as depression,
cardiovascular risk factors, and neurological disorders steadily increased over time in
patients with sleep disturbances.
Conclusion: TC increased over time in patients with sleep disturbances while LOS
and MR decreased. Further, research should focus on identifying the mechanisms that
explain the association between increasing sleep disturbance rates and expenditures
within hospital settings and the potential hospital expenditures of unrecognized sleep
disturbances in the elderly.
Keywords: sleep disturbances, sleep disorders, inpatient sample, co-morbidity, length of stay, health care cost,
mortality, older adults
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INTRODUCTION
Around half of community-dwelling older adults report sleep
concerns (Neikrug and Ancoli-Israel, 2010), with overt sleep
disorders frequently observed in this population (Wolkove et al.,
2007; Neikrug and Ancoli-Israel, 2010; Roepke and Ancoli-
Israel, 2010). Specifically, insomnia and obstructive sleep apnea
(OSA) are two common disorders affecting Americans 60 years
and older (Wolkove et al., 2007; Neikrug and Ancoli-Israel,
2010). The hospital, an under-studied setting, is pertinent since
undetected or poorly treated sleep disturbances may account for
poor prognosis and long-term utilization of hospital services,
thereby increasing healthcare expenditures. As such, this study
assesses trends of diagnosed sleep disturbances among older
adults within the hospital setting and tests test whether these
diagnoses rates are associated with hospitalization metrics (e.g.,
length of stay, mortality risk, and expenditures).
Sleep disturbances are typically comorbid with medical
conditions (Gamaldo et al., 2012b), with the latter presenting
obvious and unmanageable symptoms driving older adults to
seek treatment in these settings. Those co-morbidities include
heart disease (Budhiraja et al., 2011), hypertension (Budhiraja
et al., 2011), diabetes (Gottlieb et al., 2005), stroke (Olafiranye
et al., 2013), immune system dysfunction (Gamaldo et al., 2012b),
stomach ulcers (Budhiraja et al., 2011), arthritis (Budhiraja et al.,
2011), migraine (Budhiraja et al., 2011), asthma (Budhiraja
et al., 2011), chronic obstructive pulmonary disease(COPD;
Budhiraja et al., 2011), neurological complaints(Wolkove et al.,
2007; Budhiraja et al., 2011), endocrine dysfunction (Budhiraja
et al., 2011), depression and anxiety (Benca, 2014; Jaramillo
et al., 2015). Severe levels of co-morbidity both threaten optimal
patient care and constitute a public health and safety concern.
Chronic untreated sleep disturbances are also linked to impaired
cognitive functioning (Gamaldo et al., 2010, 2012a; Zimmerman
and Aloia, 2012; Ford et al., 2015), increased traffic accidents
(Terán-Santos et al., 1999; Budhiraja et al., 2011), worse quality
of life (Daley et al., 2009; Ford et al., 2015), increased risk
for disability (Daley et al., 2009; Ford et al., 2015), worse
workplace productivity (Leger et al., 2012; Ford et al., 2015),
and increased mortality (Hublin et al., 2011; Ford et al., 2015),
exerting significant economic strain on the healthcare system
(Peppard et al., 2013; Shear et al., 2014; Ford et al., 2015).
With population aging, healthcare service consumption will
continuously increase amongst this demographic group at
risk for developing and/or exacerbating ailments (Kaufmann
et al., 2013). Evaluated as common in samples of community-
dwelling older adults (Foley et al., 1995), sleep disturbances’
rates remain largely unknown among older adult hospital
inpatients. Exploring the hospital setting may support the need
for healthcare providers to effectively recognize and treat sleep
Abbreviations: AHRQ, Agency for Healthcare Research and Quality; AIDS,
Acquired Immune Deficiency Syndrome; CHF, Congestive Heart Failure; CI,
Confidence Interval; HCUP, Healthcare Cost and Utilization Project; ICD-9-CM,
International Classification of Diseases, Ninth Revision, Clinical Modification;
LOS, length of stay; MR, Mortality risk; NIS, Nationwide Inpatient Sample; OR,
Odds Ratio; OSA, Obstructive Sleep Apnea; OSD, Other sleep disturbances; SE,
Standard Error; SID, State Inpatient Databases; TC, total charges.
disturbances among older adults, especially if estimated sleep
disturbance rates are lower than previously reported, suggesting
under-reporting. Despite prior focus on the impact of sleep
disturbances on older adults’ physical and/or mental health
(Wolkove et al., 2007; Gamaldo et al., 2010; Neikrug and Ancoli-
Israel, 2010; Roepke and Ancoli-Israel, 2010), fewer studies
examined the ramifications of older adults’ sleep disturbances
on their interface with the healthcare system particularly as it
pertains to inpatient hospital stays. Limited research is available
to understand sleep disturbance rates among older adults,
examine trends over time, and assess whether co-morbidities
and other individual-level and hospital-level characteristics are
related to a sleep disturbance diagnosis (i.e., insomnia, OSA, or
other sleep disturbance) and hospitalization outcomes.
The current study investigated five key objectives: (A) To
assess over time trends in the rates of insomnia, OSA, and
other sleep disturbances (OSD) among hospitalized older adults;
(B) To compare patients with and without each of the three
classes of sleep disturbance, in terms of co-morbidities, patient-
level, and hospital-level characteristics in a recent period of time;
(C) To compare hospitalization outcomes in patients with and
without each of the three classes of sleep disturbance, mortality
risk (MR), length of stay (LOS), and total charges (TC) in a
recent period of time; (D) To examine trends in co-morbidity
rates and outcomes of hospitalization among patients with each
of the three classes of sleep disturbance; (E) To assess the
predictive value of patient-level and hospital-level characteristics
on outcomes of hospitalization among recently admitted patients
with any of the three classes of sleep disturbance.
MATERIALS AND METHODS
Database and Study Participants
The Nationwide Inpatient Sample (NIS) is one of several
databases and software tools implemented by the Healthcare
Cost and Utilization Project (HCUP)1, a federal-state-industry
partnership sponsored by the Agency for Healthcare Research
and Quality (AHRQ). To date, the NIS is the largest all-payer
hospital inpatient care database in the United States. Each
year, NIS collects data on nearly 7–8 million hospital stays,
reflecting discharges from ∼1000 hospitals, a probability sample
from HCUP State Inpatient Databases (SID). The sampling
probability is ∼20% and the design is stratified covering U.S.
non-rehabilitation, community hospitals, with all acute care
hospital discharges in theUnited States as the target universe. The
NIS was developed to provide information on hospital utilization,
charges, and quality of care in the United States
NIS defined its sampling strata using five hospital
characteristics contained in the AHA hospital files: (1)
Geographic Region—Northeast, Midwest, West, and South;
(2) Control—public, private not-for-profit, and proprietary;
(3) Location—urban or rural; (4) Teaching Status—teaching or
non-teaching, (5) Bed Size—small, medium, and large.
1Healthcare Cost and Utilization Project (HCUP), Nationwide Inpatient Sample
(NIS) Documentation. Available online at: http://www.hcup-us.ahrq.gov/db/
nation/nis/nisdbdocumentation.jsp (Accessed February 5, 2015).
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The NIS includes clinical and resource-use information
contained within a typical discharge abstract, protecting privacy
of patients, physicians, and hospitals. Although NIS data
are available since 1988, severity and comorbidity measures
contained in the severity file became available from 2002
onwards. In addition, NIS did not add new states to its 35-state
geographical coverage since 2002 providing more homogeneity
in data acquisition over time. Therefore, we used NIS data from
2002 to 2012. Despite the redesign made in 2012, examining
trends in means and proportions over the years is possible by
inclusion of trend weights, allowing for comparable estimates for
all years. (See Appendix I for more details).
Diagnostic Criteria
Each year, the core file of NIS provided the International
Classification of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) codes for diagnosis and procedure, from
discharge abstract, with information recoded retrospectively.
The latest changes to ICD-9-CM codes are provided
for 2011: http://www.cdc.gov/nchs/data/icd/ICD-9-CM
%20TABULARADDENDAfy12.pdf. The number of diagnoses
provided per patient varied by State. However, the number was
truncated at 15 for both diagnoses and procedures because few
cases had more than 15 diagnoses or procedures between 2002
and 2008. Nevertheless, two variables were provided indicating
the total number of diagnoses and procedures. Between 2009
and 2012, up to 25 diagnoses were provided. However, for
equal opportunity for a specific diagnosis, only the first 15 were
considered for any year.
Among the possible 15 diagnoses, the first ranked diagnosis
is termed “principal diagnosis.” In our main analysis, trends,
characteristics, and outcomes of sleep disturbance as “any
diagnosis” of 15 was of primary interest. ICD-9-CM codes used
for each class of sleep disturbance as determined by clinical sleep
specialist are outline in Appendix II.
Co-morbidity Measure
The AHRQ comorbidity measures identify coexisting medical
conditions not directly related to principal diagnosis or main
reason for admission, and are likely to have originated before
hospital stay. The AHRQ comorbidity measures were developed
as one of the HCUP tools. Complete documentation on
the comorbidity measures is available on the HCUP User
Support Website under Tools & Software. (http://www.hcup-
us.ahrq.gov/toolssoftware/comorbidity/comorbidity.jsp). In the
present study, all 29 co-morbidities (http://www.hcup-us.ahrq.
gov/toolssoftware/comorbidity/Table2-FY12-V3_7.pdf) were
included in our analyses. In particular, we examined the
likelihood of specific co-morbid conditions among patients
with conditions of “insomnia,” “OSA,” and “OSD” and how this
likelihood changed over the years.
Outcome Measures
Three outcome measures of hospitalization were considered,
MR upon discharge (0, discharged alive; 1, discharged dead),
LOS (days) and TC ($). In particular, we were interested in
comparing outcomes in patients with and without a particular
“sleep disturbance” in 2012 and examining changes over time
among patients with a sleep disturbance between the years of
2002 and 2012. For TC trends, values were inflated to 2012 dollars
using the consumer price index.
Covariates
Patient-Level Characteristics
Among patient-level characteristics, we included age (continuous
and categorized as 60–64, 65–69, 70–74, 75–79, 80–84, and 85+),
sex, race (White, Black, Hispanic, Asian/Pacific Islander, Native
American, and Other), median household income for zip code
of patient (expressed as quartiles), insurance status (Medicare,
Medicaid, Private insurance, self-pay, no charge and other) and
admission day (weekday vs. weekend).
Hospital-Level Characteristics
We examined hospital-level characteristics in relation to “sleep
disturbance” status and outcomes of healthcare utilization,
which included bed size (Small, Medium, Large), ownership
of hospital (Government/nonfederal, private non-profit, private
investor-owned), location/teaching status of the hospital (rural,
urban, non-teaching, urban teaching) and region of the hospital
(Northeast, Midwest, South and West).
Statistical Analysis
We used Stata 13.0 (StataCorp, College Station, TX), (STATA,
2013) to analyze data while accounting for survey design
complexity based on guidelines outlined by HCUP NIS through
incorporation of sampling weights, primary sampling units
and strata. Population estimates of proportions, means, and
regression coefficients were made (svy commands; Stata, 2013).
Standard errors were estimated using Taylor series linearization,
taking into account sampling weights, strata (combination of five
hospital characteristics) and primary sampling units (hospital
ID). Multiple regression modeling was also conducted, mainly
using linear and logistic regression models, while accounting
for sampling design complexity. When waves were combined
to examine trends of sleep disturbance rates and outcomes of
hospitalization, trend weights were used to ensure redesigned
2012 NIS could be incorporated into the analysis of trends. In
order to facilitate analysis of trends using multiple years of NIS
data, AHRQ developed new discharge trend weights for the
1993–2011 NIS. These weights were calculated in the same way
as the weights for the redesigned 2012 NIS, and were designed
for use instead of the original NIS discharge weights for trends
analysis. Given that our present trend analysis spans through
2012, starting from 2002, trend weights were used before 2012
data to make estimates comparable to the new 2012 NIS design.
Following our key objectives: (A) We first explored
proportions of adults 60 years or older who were diagnosed with
“insomnia,” “OSA,” or “OSD” as any of 15 possible recorded
diagnoses upon discharge. This analysis was conducted from
2002 to 2012, stratifying by sex and age groups. Overall, within
each sex and sex-age groups, we assessed trends by conducting
logistic regression analyses with year as the only covariate and
“sleep disturbance status” status the binary outcome. (B) Sleep
disturbance status (yes vs. no) among patients for the year
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2012—the most recent available year in NIS—were compared by
logistic regression with various predictors of sleep disturbance,
including patient-level and hospital-level characteristics as
well as patient co-morbidities; (C) Using 2012 wave of data
among older adults aged 60 years or older, we also compared
outcomes of hospitalizations for sleep disturbance and non-sleep
disturbance patients by logistic and linear regression models
with insomnia, OSA, and OSD status as the main predictor of
those outcomes, controlling for patient-level, and hospital-level
characteristics, and co-morbidities; (D) Using data from 2002
through 2012, we conducted a trends analysis of co-morbidities
among patients with each of the three classes of sleep disturbance,
by estimating proportions with their SE and conducting a logistic
regression model for each comorbidity with year being the
only predictor. Similarly, we examined trends in MR, LOS, and
TC using the same methods (i.e., proportion estimation and
multiple regression models with year as the only covariates)
among patients with each class of sleep disturbance. Another
linear model was also conducted to examine the net trend in
those three parameters after adjustment for age, sex, and total
number of co-morbidity; (E) Finally, and using analyses similar
to (C) but restricting the sample to patients with any sleep
disturbance, we ran several regression models testing predictors
of hospitalization outcomes in 2012 among older adults, while
including insomnia, OSA andOSD status as additional covariates
in the model. The secondary analysis of NIS was approved by
the institutional review boards of the NIH and Johns Hopkins
School of Medicine.
RESULTS
Of 87,039,711 patients sampled from 2002 to 2012, NIS (weighted
mean age ± SE: 47.9 ± 0.2, and weighted proportion female ±
SE: 58.5% ± 0.1, weighted number of discharges: 411,487,801),
35,258,031 were aged 60 years or older (weighted mean age
± SE: 75.37 ± 0.03, and weighted proportion female ± SE:
56.0% ± 0.1). The total weighted number of hospital discharges
of older adults aged 60 years or older between 2002 and 2012 was
estimated at 166,871,086 nationwide. In 2012, the unweighted
number of discharges over 60 years of age was 2,825,130; the
weighted number was 14,126,650.
Of the 35,258,031 older adults in the unweighted sample
(2002–2012), 263,865 had insomnia as “any diagnosis” (weighted
percent of discharges ± SE: 0.75 ± 0.01); 750,851 had an OSA
diagnosis (weighted percent of discharges ± SE: 2.14 ± 0.04),
21,814 had a diagnosis of OSD (weighted percent of discharges
± SE: 0.06± 0.00).
Table S1 and Figure 1 shows the trends in weighted
proportions of all three classes of sleep disturbance as any
diagnosis, stratifying by sex (Objective A). Overall and among
men and women, there was an increasing trend in the share
of hospitalizations of older adults who were diagnosed with
insomnia, OSA, and OSD. A linear trend was particularly
observed for insomnia diagnosis, with an estimated rate of 0.27%
overall in 2002 rising linearly up to 1.29% in 2012. In contrast,
OSA was not diagnosed until 2005 in this inpatient sample
(estimated rate of 0.21%) and its rate rose sharply thereafter
to reach a level of 5% out of all hospitalizations in 2012. Men
FIGURE 1 | Sex-specific and overall time trends in insomnia,
obstructive sleep apnea. (OSA) and other sleep disturbances (OSD) (as any
diagnosis) rates in the inpatient older adult population (60+y); NIS, 2002–2012.
tended to have higher rates of OSA compared to women in all
years, while the reverse gender difference was true for insomnia
(Table S1). Stratifying by both sex and age group, Table S2
and Figures 2A–F shows that in later years (particularly beyond
2009), the young-old (60–64 years) tended to have higher rates of
insomnia and OSA compared to older groups and specifically the
oldest-old (85+).
Table 1 shows the association of patient and hospital-level
characteristics with all three classes of sleep disturbance status
among hospitalized older adults (Objective B). In general,
insomnia status was positively associated with being female,
belonging to a younger age group, a White ethnicity, higher
income, having Medicare as the primary expected insurance,
admission on a weekday, admission to a small bed size (vs.
large bed size) or private, investor-owned hospital as opposed
to government, and with rural hospitalizations. Geographically
speaking, the Northeast had the lowest likelihood of insomnia
diagnosis whereas the West had the highest rates. Several
co-morbidities were more prevalent in non-insomnia cases
compared to insomnia, while others showed no difference.
The few exceptions whereby having a co-morbidity was
independently linked to higher odds of insomnia included
alcohol abuse (OR = 1.17, 95% CI:1.10–1.25, p < 0.001),
anemia (OR = 1.07, 95% CI:1.04–1.11, p < 0.001), depression
(OR = 2.73, 95%CI: 2.66–2.81, p < 0.001), drug abuse (OR
= 1.56, 95%CI:1.44–1.70, p < 0.001), hypertension (OR =
1.09, 95%CI:1.06–1.12), hypothyroidism (OR = 1.08, 95%CI:
1.05–1.11, p < 0.001), neurological disorders (OR = 1.17,
95%CI:1.13–1.21) and psychoses (OR = 1.98, 95%CI:1.89–2.08,
p < 0.001).
In contrast, the odds of an OSA diagnoses was greater
among men, but lower with age, significantly higher among
Whites and patients with higher income, and generally higher
among Medicare beneficiaries. The odds for diagnosis with
OSA was lower in weekend admissions as was insomnia, but
the odds was higher with bed size, highest in private non-
profit and urban hospitals, while remaining lowest in the
Northeast. Several co-morbidities had independent positive
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FIGURE 2 | (A–F) Sex- and age-specific time trends in insomnia, obstructive sleep apnea. (OSA) and other sleep disturbances (OSD) (as any diagnosis) rates in the
inpatient older adult population (60+y); NIS, 2002–2012.
associations with OSA and many of those intersected with
those observed with insomnia. These included rheumatoid
arthritis, congestive heart failure, depression, diabetes (both
uncomplicated and complicated), hypertension, hypothyroidism,
neurological disorders, pulmonary circulation disorders, renal
failure, and most importantly obesity (OR = 5.15, 95%CI: 5.05–
5.25, p < 0.001).
The likelihood of OSD diagnoses was not modified by
gender or income though was still lowest among the oldest-old,
and highest among Whites. Hospital-level characteristics were
associated with OSD in a way similar to that of OSA, with the
odds doubled in the Midwest compared to the Northeast. Most
notably, while alcohol abuse was inversely related to OSD, drug
abuse was among the strongest predictors of OSD (OR = 8.52,
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TABLE 1 | Associations of patient and hospital characteristics with insomnia, OSA, and OSD (1, Yes; 0, No) among the US inpatient older adult population:
multiple logistic regression models (Unweighted N = 2,825,283; Weighted N = 14,126,415)*, NIS 2012.
Unwt. N* Wt. % ± SE* Insomnia OSA OSD
60 + y, 2012 OR** 95% CI P OR** 95% CI P OR** 95% CI P
Female 1,677,164 55.1±0.1 1.19 (1.16;1.22) < 0.001 0.53 (0.52;0.54) < 0.001 0.98 (0.90;1.07) 0.71
AGE GROUP
60–64 503,657 16.5±0.1 1 1 1
65–69 531,122 17.4±0.1 0.91 (0.88;0.95) < 0.001 0.89 (0.87;0.91) < 0.001 0.95 (0.83;1.10) 0.53
70–74 490,322 16.1±0.0 0.90 (0.86;0.94) < 0.001 0.78 (0.77;0.80) < 0.001 1.02 (0.87;1.19) 0.83
74–79 470,935 15.5±0.0 0.89 (0.85;0.93) < 0.001 0.64 (0.62;0.65) < 0.001 0.90 (0.76;1.06) 0.21
80–84 452,445 14.9±0.0 0.84 (0.80;0.88) < 0.001 0.48 (0.46;0.49) < 0.001 0.82 (0.69;0.98) 0.027
85+ 597,194 19.6±0.0 0.76 (0.73;0.80) < 0.001 0.26 (0.25;0.27) < 0.001 0.72 (0.61;0.86) < 0.001
RACE
1 = White 2,232,525 77.3±0.4 1 1 1
2 = Black 312,331 10.8±0.0 0.62 (0.59;0.66) < 0.001 0.88 (0.85;0.92) < 0.001 0.66 (0.56;0.79) < 0.001
3 = Hispanic 194,468 6.7±0.0 0.87 (0.81;0.94) < 0.001 0.63 (0.60;0.67) < 0.001 0.67 (0.53;0.87) 0.002
4 = Asian/Pacific Islander 58,023 2.0±0.0 0.87 (0.78;0.97) 0.014 0.47 (0.43;0.52) < 0.001 0.67 (0.44;1.01) 0.05
5 = Native American 15,399 0.5±0.1 0.84 (0.70;1.00) 0.05 0.93 (0.78;1.11) 0.44 0.31 (0.13;0.75) 0.009
6 = Other 76,738 2.7±0.2 0.96 (0.87;1.06) 0.47 0.72 (0.67;0.79) < 0.001 1.03 (0.80;1.32) 0.81
MEDIAN HH INCOME FOR ZIP CODE OF PATIENT
1st quartile 873,930 29.3±0.5 1 1 1
2nd quartile 754,442 25.3±0.4 1.01 (0.97;1.05) 0.62 1.09 (1.06;1.12) < 0.001 0.97 (0.85;1.10) 0.65
3rd quartile 710,554 23.8±0.3 1.04 (1.00;1.09) 0.08 1.16 (1.13;1.20) < 0.001 0.95 (0.82;1.09) 0.47
4th quartile 646,730 21.7±0.5 1.08 (1.02;1.14) 0.008 1.20 (1.15;1.24) < 0.001 1.08 (0.93;1.25) 0.33
INSURANCE STATUS
Medicare 2,432,075 80.0±0.2 1 1 1
Medicaid 100,551 3.3±0.1 0.90 (0.83;0.96) 0.003 0.69 (0.66;0.73) < 0.001 0.68 (0.52;0.91) 0.008
Private insurance 409,617 13.4±0.2 0.97 (0.93;1.02) 0.25 1.01 (0.98;1.03) 0.49 1.10 (0.96;1.26) 0.16
Self-pay 39,753 1.3±0.0 0.71 (0.61;0.82) < 0.001 0.49 (0.45;0.54) < 0.001 0.91 (0.60;1.39) 0.67
No charge 3441 0.1±0.0 1.03 (0.73;1.46) 0.87 0.56 (0.41;0.76) < 0.001 1.08 (0.34;3.41) 0.89
Other 54,012 1.8±0.1 0.86 (0.78;0.95) 0.003 0.86 (0.81;0.90) < 0.001 0.84 (0.60;1.17) 0.29
ADMISSION DAY
Weekday 2,440,195 80.1±0.0 1 1 1
Weekend 605,477 19.9±0.1 0.95 (0.93;0.98) 0.001 0.94 (0.92;0.95) < 0.001 0.91 (0.81;1.01) 0.08
CO-MORBIDITY
AIDS 2002 0.1±0.0 0.61 (0.34;1.10) 0.10 0.47 (0.34;0.65) < 0.001 0.70 (0.10;5.02) 0.72
Alcohol Abuse 80,337 2.6±0.0 1.17 (1.10;1.25) < 0.001 0.59 (0.56;0.61) < 0.001 0.72 (0.55;0.95) 0.018
Deficiency Anemia 670,473 22.0±0.1 1.07 (1.04;1.11) < 0.001 0.92 (0.91;0.94) < 0.001 0.97 (0.86;1.09) 0.57
Rheumatoid
arthritis/collagen vascular
disease
108,420 3.6±0.0 1.01 (0.95;1.06) 0.82 1.18 (1.15;1.22) < 0.001 1.14 (0.93;1.39) 0.20
Chronic blood loss anemia 39,495 1.3±0.0 0.98 (0.87;1.10) 0.71 0.79 (0.74;0.84) < 0.001 1.01 (0.68;1.50) 0.96
Congestive heart failure 420,652 13.8±0.1 0.77 (0.74;0.80) < 0.001 1.37 (1.34;1.39) < 0.001 0.80 (0.69;0.92) 0.002
Chronic pulmonary disease 720,894 23.7±0.1 0.97 (0.94;0.99) < 0.001 1.79 (1.76;1.81) < 0.001 1.02 (0.93;1.13) 0.63
Coagulopathy 176,187 5.8±0.0 0.80 (0.76;0.85) < 0.001 0.88 (0.86;0.91) < 0.001 0.61 (0.47;0.78) < 0.001
Depression 356,534 11.7±0.1 2.73 (2.66;2.81) < 0.001 1.37 (1.35;1.43) < 0.001 1.99 (1.80;2.21) < 0.001
Diabetes, uncomplicated 802,141 26.3±0.1 0.73 (0.71;0.76) < 0.001 1.50 (1.48;1.52) < 0.001 0.84 (0.76;0.93) 0.001
Diabetes, complicated 179,761 5.9±0.1 0.69 (0.65;0.73) < 0.001 1.39 (1.35;1.43) < 0.001 0.79 (0.64;0.98) 0.036
Drug abuse 29,617 0.1±0.0 1.56 (1.44;1.70) < 0.001 0.72 (0.68;0.77) < 0.001 8.52 (7.02;10.34) < 0.001
Hypertension 2,109,734 69.3±0.1 1.09 (1.06;1.12) < 0.001 1.21 (1.20;1.23) < 0.001 1.02 (0.93;1.12) 0.62
Hypothyroidism 512,730 16.8±0.1 1.08 (1.05;1.11) < 0.001 1.22 (1.20;1.24) < 0.001 1.15 (1.03;1.28) 0.013
Liver disease 72,826 2.4±0.0 0.91 (0.84;0.97) 0.009 0.86 (0.83;0.90) < 0.001 0.86 (0.63;1.17) 0.34
(Continued)
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TABLE 1 | Continued
Unwt. N* Wt. % ± SE* Insomnia OSA OSD
60 + y, 2012 OR** 95% CI P OR** 95% CI P OR** 95% CI P
Lymphoma 34,835 1.1±0.0 0.94 (0.84;1.04) 0.23 0.84 (0.79;0.90) < 0.001 0.81 (0.51;1.28) 0.38
Fluid/electrolyte disorders 897,369 29.5±0.1 0.92 (0.90;0.95) < 0.001 0.82 (081;0.83) < 0.001 0.83 (0.75;0.92) 0.001
Metastatic cancer 90,230 3.0±0.0 0.83 (0.77;0.89) < 0.001 0.52 (0.50;0.55) < 0.001 0.61 (0.44;0.84) 0.003
Neurological disorders 301,899 9.9±0.0 1.17 (1.13;1.21) < 0.001 1.13 (1.10;1.15) < 0.001 1.52 (1.35;1.71) < 0.001
Obesity 329,904 10.8±0.1 0.90 (0.86;0.93) < 0.001 5.15 (5.05;5.25) < 0.001 1.36 (1.20;1.54) < 0.001
Paralysis 88,068 2.9±0.0 0.93 (0.86;1.00) 0.042 0.68 (0.65;0.71) < 0.001 1.18 (0.91;1.54) 0.20
Peripheral vascular
disorders
292,442 9.6±0.0 0.80 (0.76;0.83) < 0.001 0.83 (0.81;0.85) < 0.001 0.85 (0.72;1.01) 0.07
Psychoses 111,610 3.7±0.0 1.98 (1.89;2.08) < 0.001 0.95 (0.91;0.98) 0.003 1.75 (1.47;2.10) < 0.001
Pulmonary circulation
disorders
97,609 3.2±0.0 0.79 (0.76;0.83) < 0.001 1.70 (1.65;1.75) < 0.001 0.98 (0.75;1.28) 0.90
Renal failure 562,107 18.5±0.1 0.73 (0.71;0.76) < 0.001 1.14 (1.12;1.17) < 0.001 0.70 (0.61;0.80) < 0.001
Non-metastatic cancer 91,610 3.0±0.0 0.97 (0.91;1.03) 0.28 0.72 (0.70;0.75) < 0.001 0.65 (0.47;0.92) 0.014
Peptic ulcer 1222 0.0±0.0 1.09 (0.67;1.78) 0.72 0.68 (0.48;0.95) 0.025 4.58 (1.72;12.20) 0.002
Valvular disease 176,782 5.8±0.1 0.98 (0.93;1.04) 0.53 0.99 (0.96;1.02) 0.40 1.14 (0.94;1.39) 0.18
Weight loss 193,961 6.4±0.1 0.84 (0.80;0.89) < 0.001 0.45 (0.44;0.47) < 0.001 0.90 (0.74;1.09) 0.29
BED SIZE
Small 458,999 15.0±0.0 1 1 1
Medium 801,171 26.3±0.0 0.95 (0.89;1.02) 0.17 1.06 (1.00;1.12) 0.048 0.96 (0.80;1.16) 0.70
Large 1,785,505 58.6±0.0 0.92 (0.87;0.98) 0.010 1.11 (1.05;1.17) < 0.001 0.80 (0.67;0.95) 0.009
OWNERSHIP OF HOSPITAL
Government, nonfederal 321,524 10.6±0.0 1 1 1
Private, non-profit 2,275,706 74.7±0.0 1.02 (0.94;1.10) 0.71 1.12 (1.04;1.20) 0.003 1.26 (1.04;1.53) 0.019
Private, investor-own 448,445 14.7±0.0 1.11 (1.01;1.22) 0.033 0.98 (0.90;1.07) 0.61 1.10 (0.86;1.40) 0.47
LOCATION/TEACHING STATUS
Rural 404,639 13.3±0.0 1 1 1
Urban, non-teaching 1,232,393 40.5±0.0 0.80 (0.74;0.85) < 0.001 1.23 (1.16;1.32) < 0.001 0.77 (0.65;0.91) 0.002
Urban, teaching 1,408,643 46.3±0.0 0.82 (0.76;0.88) < 0.001 1.46 (1.37;1.56) < 0.001 0.70 (0.59;0.83) < 0.001
REGION OF HOSPITAL
Northeast 612,680 20.1±0.4 1 1 1
Midwest 715,874 23.5±0.4 1.27 (1.17;1.38) < 0.001 1.36 (1.27;1.45) < 0.001 2.00 (1.67;2.40) < 0.001
South 1,175,080 38.6±0.5 1.44 (1.33;1.56) < 0.001 1.18 (1.11;1.25) < 0.001 1.75 (1.47;2.07) < 0.001
West 542,041 17.8±0.3 1.61 (1.48;1.76) < 0.001 1.12 (1.04;1.21) < 0.001 1.58 (1.29;1.93) < 0.001
Female 1,677,164 55.1±0.1 1.19 (1.16;1.22) < 0.001 0.53 (0.52;0.54) < 0.001 0.98 (0.90;1.07) 0.71
NIS, Nationwide Inpatient Sample; OSA, Obstructive Sleep Apnea; OSD, Other Sleep Disturbances; Unwt, Unweighted; Wt, Weighted.
*Sample sizes and % were based on data availability per covariate among older adults 60 + y in the NIS 2012. Unweighted and weighted N are based on simultaneous availability of
data in the logistic regression models.
**Odds ratios (OR) are estimated from a multiple logistic regression model with their 95% confidence interval (CI) and thus are multivariate-adjusted for all covariates included in the
model. OR are interpreted as the odds of having the outcome of interest among the exposed group(s) relative to the odds of having the outcome of interest among the unexposed
group (referent category), controlling for all other covariates in the model.
95%CI:7.02–10.34, p < 0.001) followed by peptic ulcer (OR =
4.58, 95%CI:1.72–12.20, p = 0.002). Other co-morbidities that
were positively linked to OSD included depression, hypertension,
neurological disorders, obesity, and psychoses.
Table 2 displays findings from multiple regression models
testing associations between the three classes of sleep disturbance
as predictors of MR, LOS, and TC, while adjusting for individual-
level and hospital-level characteristics (Objective C). Generally,
diagnosis with any of the three sleep disturbances was associated
with lower MR and lower TC compared to non-diagnosis. LOS
was higher for insomnia vs. non-insomnia and for OSD vs.
non-OSD, though the reverse pattern was observed for OSA
status.
Among hospitalized older adults who were diagnosed with
each of the three classes of sleep disturbances, trends in co-
morbidities from 2002 to 2012 are presented in Table S3
(Objective D). Overall, the average number of co-morbidities
increased steadily from 2.28 in 2002 to 3.10 in 2012 for insomnia,
from 3.11(2005) to 3.87(2012) for OSA and 1.92(2002) to
3.19(2012) for OSD. Some of the most prevalent co-morbidities
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TABLE 2 | Outcomes of healthcare utilization (MR, LOS, and TC) among older adults by sleep disturbance status, patient-level, and hospital-level
characteristics: multiple logistic and OLS regression models, NIS 2012.
Model 1: MR Model 2: LOS (days) Model 3: TC ($)
OR** 95% CI P β** (SE) P β** (SE) P
INSOMNIA STATUS
Non-insomnia 1 – –
Insomnia (any diagnosis) 0.36 (0.32;0.40) <0.001 +0.44 (0.05) <0.001 –4715 (339) <0.001
OSA STATUS
Non-OSA 1 – –
OSA (any diagnosis) 0.58 (0.56;0.61) <0.001 –0.34 (0.02) <0.001 –2125 (316) <0.001
OSD STATUS
Non-OSD 1 – –
OSD (any diagnosis) 0.35 (0.23;0.54) <0.001 +0.40 (0.12) 0.001 –5853 (787) <0.001
Unwt. N* 2,824,671 2,825,124 2,767,001
Wt. N* 14,123,355 14,125,620 13,835,005
LOS, Length of stay; MR, mortality Risk; NIS, Nationwide Inpatient Sample; OSA, Obstructive Sleep Apnea; OSD, Other Sleep Disturbances; TC, Total Charges; Unwt, Unweighted; Wt,
Weighted.
*Weighted and unweighted sample sizes are based on multiple logistic regression models with outcome being “all sleep disturbances.”
**Odds ratios (OR) are estimated from a multiple logistic regression model with their 95% confidence interval (CI) and linear regression coefficients (β) are estimated from multiple ordinary
least square (OLS) models with their standard errors (SE) and thus are multivariate-adjusted for all covariates included in the model. OR are interpreted as the odds of mortality among
the exposed group(s) relative to the odds of mortality among the unexposed group (referent category), controlling for all other covariates in the model. β is the estimated adjusted
difference in LOS or TC between referent and exposure category(ies). All models controlled for sex, age, race, income, insurance status, admission day, co-morbidity, hospital bed size,
ownership of hospital, location/teaching status, and region of the hospital.
(>10% in 2012) in insomnia patients included deficiency anemia
(∼14% in 2002 → 21% in 2012), chronic pulmonary disorder
(22% in 2002 → 24% in 2012), depression (20% in 2002
→ 27% in 2012), uncomplicated diabetes (∼15% in 2002 →
21% in 2012), hypertension (52% in 2002 → 70% in 2012),
hypothyroidism (14% in 2002→ 20% in 2012), fluid/electrolyte
disorder (18% in 2002→ 27% in 2012), neurological disorders
(6.3% in 2002 →12.5% in 2012), and renal failure (3% in
2002 → 12% in 2012). Except for congestive heart failure,
the rates among insomnia patients rose over time for most
co-morbidities. Among OSA patients, the most prevalent co-
morbidities included those observed among insomnia patients in
addition to obesity (42% in 2012) and congestive heart failure
(19% in 2012). Despite similar comorbidity patterns between
the three classes of sleep disturbance, OSD had the highest co-
morbidity with drug abuse compared to insomnia andOSA (7.5%
in 2012 vs. 1.8 for insomnia and 0.9% in OSA).
In parallel with the rise in co-morbidities among older adult
patients with sleep disturbance, TC rose steadily from an average
of $22,250/admission in 2002 to $38,177/admission in 2012
for insomnia with similar mean annual changes observed for
OSA and OSD ($1414/year for OSA, $1635/year for OSD and
$1722/year for insomnia). The rate of increase in cost was slightly
attenuated but remained significant after adjustment for age, sex,
and total number of co-morbidities. However, both MR and LOS
have beenmarkedly reduced over-time, with the exception of MR
for OSD (p> 0.05). In particular, MR dropped steadily from 1.5%
in 2002 to 1.0% in 2012 among insomnia patients while mean
LOS was reduced from 6.1 days in 2002 to 5.4 days in 2012. Those
rates of decrease over time were even more marked after control
was made on age, sex, and total number of co-morbidities (Table
S4,Objective D).
Using data from 2012 on inpatient older adults with “any sleep
disturbance,” we tested predictors of outcomes of hospitalization
(Table 3, Objective E). MR was lower among women who also
had a significantly lower TC. MR increased linearly with age,
with longer LOS but lower TC observed in the older groups.
TC was also higher among Hispanics and other ethnic groups
compared to Whites, with Blacks having significantly lower MR
and higher LOS compared to Whites. The 4th quartile of income
was significantly more expensive in terms of TC compared to the
1st quartile, though LOS was shorter and MR lower.
DISCUSSION
This study is the first to utilize a large national healthcare
database to comprehensively examine trends in sleep disturbance
diagnoses of insomnia, OSA, and OSD among hospitalized older
adults in the United States and whether co-morbidities and
outcomes are related to disturbance status. Moreover, this study
tested both patient-level and hospital-level predictors of sleep
disturbance status and outcomes of hospitalization.
Our study observed that the proportion of older adults with a
sleep diagnosis has increased significantly over the last decade.
Insomnia and OSA diagnoses in older adults have more than
tripled from 2002 to 2012, while diagnoses for OSD have almost
doubled over this period. A study using the National Health
Interview Survey (Ford et al., 2015) observed similar increasing
rate trends specifically for insomnia from 2002 (17.5%) and
2012 (19.2%) with adults 18 years and older. The study also
observed greater rate changes over time for the youngest-old
(55–64 years: 22.1–24.2%) and middle-old (65–74 years: 18.6–
21.3%) than the oldest-old (75 years and older: 20.5–20.7%) age
groups. The current study expands upon these findings, in that
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TABLE 3 | Outcomes of healthcare utilization (MR, LOS, and TC) among older adults with “any sleep disturbance,” patient-level and hospital-level
characteristics: multiple logistic and OLS regression models, NIS 2012.
Model 1: MR Model 2: LOS(days) Model 3: TC ($)
Unwt. N* Wt. % ± SE* OR 95% CI P β (SE) P β (SE) P
Insomnia (yes vs. no) 39,430 20.5±0.3 0.35 (0.18;0.69) 0.003 +0.09 (0.10) 0.34 −3424 (1143) 0.003
OSA (yes vs. no) 152,299 79.2±0.3 0.56 (0.28;1.12) 0.10 −0.62 (0.11) < 0.001 +2222 (1126) 0.049
Other disturbance (yes vs.
no)
2249 1.3±0.0 0.35 (0.15;0.82) 0.015 +0.07 (0.64) 0.64 −4788 (1259) < 0.001
Female 90,673 47.2±0.2 0.91 (0.84;1.00) 0.045 −0.04 (0.03) 0.18 −2984 (292) < 0.001
AGE
60–64 45,224 23.5±0.1 1 – –
65–69 45,694 23.8±0.1 1.29 (1.12;1.51) 0.001 +0.03 (0.04) 0.44 +507 (447) 0.26
70–74 37,005 19.2±0.1 1.64 (1.40;1.93) < 0.001 +0.10 (0.05) 0.046 −1106 (527) 0.036
74–79 28,279 14.7±0.1 1.82 (1.54;2.14) < 0.001 +0.18 (0.05) 0.001 −2752 (552) < 0.001
80–84 20,166 10.5±0.1 2.22 (1.87;2.62) < 0.001 +0.33 (0.06) < 0.001 −4413 (607) < 0.001
85+ 15,956 8.3±0.1 3.07 (2.58;3.65) < 0.001 +0.21 (0.08) 0.011 −9022 (653) < 0.001
RACE
1 = White 147,852 81.6±0.4 1 – –
2 = Black 18,194 10.0±0.3 0.82 (0.71;0.95) 0.007 +0.15 (0.06) 0.011 +442 (946) 0.64
3 = Hispanic 8542 4.7±0.2 1.00 (0.83;1.20) 0.97 +0.03 (0.09) 0.70 +6356 (1449) < 0.001
4 = Asian/Pacific Islander 1776 1.0±0.1 1.04 (0.73;1.49) 0.81 +0.29 (0.17) 0.09 +3430 (2743) 0.21
5 = Native American 961 0.5±0.1 1.09 (0.66;1.80) 0.73 −0.01 (0.22) 0.97 −7306 (3649) 0.045
6 = Other 3792 2.1±0.2 0.91 (0.68;1.20) 0.49 +0.23 (0.11) 0.039 +5045 (2487) 0.043
MEDIAN HH INCOME FOR ZIP CODE OF PATIENT
1st quartile 51,128 27.1±0.5 1 – –
2nd quartile 48,773 25.8±0.4 0.95 (0.86;1.06) 0.37 −0.15 (0.04) < 0.001 −181 (553) 0.74
3rd quartile 48,015 25.4±0.4 0.85 (0.76;0.95) 0.005 −0.19 (0.05) < 0.001 +1045 (657) 0.11
4th quartile 41,027 21.7±0.6 0.80 (0.70;0.90) < 0.001 −0.29 (0.05) < 0.001 +4623 (1001) < 0.001
INSURANCE STATUS
Medicare 147,649 76.9±0.2 1 – –
Medicaid 5650 2.9±0.7 1.34 (1.04;1.74) 0.026 +0.83 (0.18) < 0.001 −1050 (956) 0.27
Private insurance 33,410 17.4±0.2 1.17 (1.00;1.35) 0.046 −0.05 (0.04) 0.18 +1622 (556) 0.004
Self-pay 1543 0.8±0.0 1.18 (0.66;1.96) 0.64 +1.06 (0.28) < 0.001 +3232 (3804) 0.40
No charge 166 0.1±0.1 0.69 (0.09;5.13) 0.72 +1.69 (1.05) 0.11 −6771 (3856) 0.08
Other 3618 1.9±0.1 2.30 (1.77;2.99) < 0.001 +0.15 (0.11) 0.18 +1076 (1159) 0.35
ADMISSION DAY
Weekday 157,416 81.8±0.1 1 – – −
Weekend 34,908 18.2±0.1 1.41 (1.29;1.54) < 0.001 −0.12 (0.03) 0.001 −6191 (359) < 0.001
CO-MORBIDITY
AIDS 64 0.0±0.0 – – −0.13 (0.70) 0.86 +5272 (10,096) 0.60
Alcohol Abuse 4114 2.1±0.0 1.06 (0.80;1.41) 0.66 +0.37 (0.10) < 0.001 −2616 (1,011) 0.010
Deficiency Anemia 40,039 20.8±0.2 0.94 (0.85;1.03) 0.21 +0.96 (0.04) < 0.001 +5761 (449) < 0.001
Rheumatoid
arthritis/collagen vascular
disease
7661 4.0±0.1 1.02 (0.83;1.26) 0.85 +0.02 (0.06) 0.70 −946 (606) 0.12
Chronic blood loss anemia 2023 1.1±0.0 0.91 (0.64;1.30) 0.62 +1.15 (0.12) < 0.001 +10,899 (1419) < 0.001
Congestive heart failure 33,552 17.4±0.1 1.61 (1.47;1.77) < 0.001 +0.68 (0.04) < 0.001 −1934 (402) < 0.001
Chronic pulmonary disease 66,136 34.3±0.2 1.24 (1.14;1.34) < 0.001 +0.34 (0.03) < 0.001 +2705 (349) < 0.001
Coagulopathy 9448 4.9±0.1 1.77 (1.55;2.02) < 0.001 +1.24 (0.07) < 0.001 +20,020 (1666) < 0.001
Depression 35,872 18.7±0.2 0.82 (0.73;0.92) 0.001 −0.06 (0.03) 0.049 −1862 (354) < 0.001
Diabetes, uncomplicated 68,935 35.8±0.2 1.07 (0.98;1.17) 0.11 +0.07 (0.03) 0.009 −1274 (303) < 0.001
Diabetes, complicated 16,689 8.7±0.1 0.81 (0.71;0.95) 0.007 +0.55 (0.05) < 0.001 +118 (657) 0.86
(Continued)
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TABLE 3 | Continued
Model 1: MR Model 2: LOS(days) Model 3: TC ($)
Unwt. N* Wt. % ± SE* OR 95% CI P β (SE) P β (SE) P
Drug abuse 2175 1.1±0.0 0.71 (0.43;1.15) 0.16 +0.16 (0.12) 0.16 −1799 (1265) 0.16
Hypertension 143,908 74.8±0.1 0.78 (0.72;0.95) < 0.001 −0.08 (0.03) 0.005 +2170 (337) < 0.001
Hypothyroidism 35,425 18.4±0.1 0.86 (0.77;0.95) 0.005 +0.02 (0.03) 0.50 +78 (324) 0.81
Liver disease 4538 2.4±0.0 1.15 (0.90;1.46) 0.26 −0.06 (0.08) 0.47 −4404 (930) < 0.001
Lymphoma 4528 0.9±0.0 1.89 (1.42;2.52) < 0.001 +0.72 (0.16) < 0.001 +259 (1606) 0.87
Fluid/electrolyte disorders 48,524 25.2±0.2 2.29 (2.10;2.50) < 0.001 +1.26 (0.04) < 0.001 +8318 (537) < 0.001
Metastatic cancer 3131 1.6±0.0 3.03 (2.48;2.50) < 0.001 +0.91 (0.12) < 0.001 +3130 (1265) 0.013
Neurological disorders 19,151 10.0±0.1 1.24 (1.10;1.40) 0.001 +0.38 (0.05) < 0.001 −539 (537) 0.32
Obesity 67,602 35.2±0.2 1.00 (0.91;1.09) 0.97 +0.48 (0.03) < 0.001 +4033 (357) < 0.001
Paralysis 4230 2.2±0.0 1.31 (1.03;1.67) 0.025 +3.56 (0.17) < 0.001 +11,422 (1620) < 0.001
Peripheral vascular
disorders
17,437 9.1±0.1 1.06 (0.94;1.21) 0.33 +0.06 (0.04) 0.12 +3507 (499) < 0.001
Psychoses 8623 4.5±0.1 0.86 (0.70;1.07) 0.18 +0.58 (0.08) < 0.001 −1471 (716) 0.040
Pulmonary circulation
disorders
10,263 5.3±0.1 1.85 (1.63;2.09) < 0.001 +0.88 (0.06) < 0.001 +4340 (776) < 0.001
Renal failure 40,066 20.8±0.2 1.58 (1.44;1.73) < 0.001 +0.13 (0.04) < 0.001 −1839 (423) < 0.001
Non-metastatic cancer 4289 2.2±0.0 1.79 (1.46;2.18) < 0.001 +0.40 (0.09) < 0.001 −2250 (841) 0.007
Peptic ulcer 60 0.0±0.0 – − −0.10 (0.58) 0.86 −1823 (5881) 0.22
Valvular disease 10,923 5.7±0.1 1.01 (0.87;1.16) 0.93 +0.06 (0.05) 0.26 −685 (556) 0.22
Weight loss 6089 3.2±0.1 2.52 (2.18;2.92) < 0.001 +3.00 (0.13) < 0.001 +22,037 (2211) < 0.001
BED SIZE
Small 26,976 14.0±0.4 1 – –
Medium 49,997 26.0±0.6 1.22 (1.05;1.41) 0.009 +0.08 (0.08) 0.30 +3889 (1263) 0.002
Large 115,351 60.0±0.7 1.36 (1.19;1.56) < 0.001 +0.52 (0.07) < 0.001 +11,453 (1278) < 0.001
OWNERSHIP OF HOSPITAL
Government, nonfederal 17,874 9.3±0.4 1 – –
Private, non-profit 149,417 77.7±0.6 0.97 (0.83;1.12) 0.83 −0.29 (0.08) < 0.001 799 (1798) 0.66
Private, investor-own 25,033 13.0±0.4 0.88 (0.73;1.06) 0.18 −0.12 (0.09) 0.18 19,837 (1939) < 0.001
LOCATION/TEACHING STATUS
Rural 21,853 11.4±0.4 1 – –
Urban, non-teaching 74,897 38.9±0.7 0.98 (0.85;1.14) 0.83 +0.51 (0.06) < 0.001 12,927 (1003) < 0.001
Urban, teaching 95,574 49.7±0.7 1.02 (0.89;1.18) 0.73 +0.90 (0.07) < 0.001 21,308 (1343) < 0.001
REGION OF HOSPITAL
Northeast 31,994 16.6±0.5 1 – –
Midwest 54,484 28.3±0.7 0.98 (0.86;1.13) 0.82 −0.51 (0.07) < 0.001 −6613 (1789) < 0.001
South 72,882 37.9±0.7 1.02 (0.90;1.16) 0.76 −0.46 (0.07) < 0.001 −5905 (1818) 0.001
West 32,964 17.1±0.5 1.09 (0.94;1.26) 0.26 −0.79 (0.09) < 0.001 +10,847 (2562) < 0.001
Unweighted sample 192,324 177,508 177,632 173,859
Weighted sample 961,620 887,540 888,160 869,295
AIDS, Acquired Immune deficiency Syndrome; CHF, Congestive Heart Failure; LOS, Length of stay; MR, mortality Risk; NIS, Nationwide Inpatient Sample; OSA, Obstructive Sleep
Apnea; OSD, Other Sleep Disturbances; TC, Total Charges; Unwt, Unweighted; Wt, Weighted.
*Sample of older adults with any sleep disturbance in 2012 having complete data on each covariates entered in the model.
we observed that the youngest-old (60–64 years) tended to have
greater rates of change for both insomnia and OSA than the
older age groups (65 years and older). A possible explanation
for this finding is that a percentage of the oldest-old with sleep
disturbances and comorbid health conditions may have died at
earlier ages. Thus, a survivor effect may be occurring where the
oldest-old adults with sleep disturbances are a selected group of
individuals with less severe sleep disturbances and/or comorbid
medical conditions. Nevertheless, a growing body of evidence
has shown that (short or long) sleep duration (Cohen-Mansfield
and Perach, 2012; Ensrud et al., 2012; Garde et al., 2013; Jung
et al., 2013; Kakizaki et al., 2013; Kurina et al., 2013; Yeo et al.,
2013; Azevedo Da Silva et al., 2014; Benito-León et al., 2014;
Duggan et al., 2014; Pan et al., 2014; Rod et al., 2014; Xiao
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et al., 2014; Cai et al., 2015; Hall et al., 2015), sleep disturbances
(Ensrud et al., 2012; Omachi et al., 2012; Rod et al., 2014), and
obstructive sleep apnea (OSA; Ge et al., 2013; Lee et al., 2013;
Lockhart et al., 2013; Muraja-Murro et al., 2013; Stanchina et al.,
2013; Kendzerska et al., 2014; Louis et al., 2014; Marshall et al.,
2014) may predict all-cause (Seicean et al., 2011; Ensrud et al.,
2012; Howrey et al., 2012; Johansson et al., 2012; Nieto et al.,
2012; Omachi et al., 2012; Garde et al., 2013; Ge et al., 2013;
Jung et al., 2013; Kakizaki et al., 2013; Kurina et al., 2013; Lee
et al., 2013; Lockhart et al., 2013; Muraja-Murro et al., 2013;
Yeo et al., 2013; Louis et al., 2014; Marshall et al., 2014; Pan
et al., 2014; Rod et al., 2014; Xiao et al., 2014; Hall et al., 2015;
Rahman and Adjeroh, 2015), cardiovascular- (Nieto et al., 2012;
Garde et al., 2013; Ge et al., 2013; Kakizaki et al., 2013; Yeo
et al., 2013; Azevedo Da Silva et al., 2014; Marshall et al., 2014;
Rod et al., 2014; Xiao et al., 2014), cancer- (Yeo et al., 2013;
Marshall et al., 2014; Rod et al., 2014; Xiao et al., 2014; Rahman
and Adjeroh, 2015), and dementia-specific (Cai et al., 2015)
mortality. Another explanation is the increased number of co-
morbidities with age that are deemed more serious to report than
sleep disturbances thus those diagnoses are often missed at older
ages given that only 15 diagnoses are allowed for this analysis.
Generally speaking, several reasons have been proposed for the
increasing sleep disturbances rates including, but not limited to,
the following: (1) increased number of health conditions; (2)
increase in obesity rates; (3) increase in perceived stress; (4) poor
sleep habits/hygiene; (5) increase in shift work; (6) increased use
of electronic devices, particularly close to bedtime, a behavior that
has become salient in the US, though possibly less so among older
adults (Pallesen et al., 2014; Ford et al., 2015).
While in-hospital LOS and MR among admissions with
sleep disturbances has decreased, TC has increased over time.
Specifically, insomnia-related hospital charges have increased
from $22,250 to $38,177, OSA-related hospital charges have
increased from $37,561 to $46,518, and OSD-related hospital
charges have increased from $18,264 to $35,450, with those
trends only partly explained by age, sex and total comorbidity
distribution changes over the years. In comparison to younger
adults, older adults have shown to incur direct (inpatient,
outpatient, pharmacy, and emergency room) charges greater
than $1253 for untreated sleep disturbances, such as insomnia
(Ozminkowski et al., 2007). Particularly in light of recent
data suggesting poorer health outcomes and increased rates
of readmission in those individuals suffering with untreated
sleep disorders, increased efforts aimed at training providers
delivering both the acute (inpatient) and primary/preventive
health care may assist in reducing hospitalization costs. The
reduction in MR and LOS may be explained by the improved
in-hospital procedures to stabilize/improve health co-morbidities
(e.g., hypertension and diabetes) often associated with sleep
disturbances. One study partially supports this explanation,
by observing that in-hospital mortality risk appeared to
decline significantly in OSA patients after adjusting for health
comorbidities and demographic characteristics (Lyons et al.,
2015). Consequently, it is possible that increased costs may be
a result of implementing a variety of in-hospital procedures
for stabilizing/improving older adults’ health status, especially if
they have complex etiologies, including sleep disturbances and
other co-morbidities, that leads to a complex case-mix requiring
multifaceted interventions. The increased costs, but reduced MR
and LOS, may also reflect enhanced techniques for early disease
detection and copious treatment resources.
Our study observed several patient characteristic differences
across the three classes of sleep disturbances. Over the last decade
men tended to have higher rates for OSA, while women tend
to have higher rates for insomnia. These gender differences in
OSA and insomnia rates have been supported in previous studies
(Ohayon et al., 2004; Wolkove et al., 2007; Salas et al., 2014).
In terms of hospitalization outcomes, women with any type
of sleep disturbance tended to have lower MR and lower TC
than men. It is unclear what physiological, sociological, and/or
psychological factors explain the gender differences in OSA,
which could assist in developing an approach for improving
hospitalization outcomes associated with OSA in men. However,
it has been proposed that estrogen deficiency, particularly during
the peri-menopausal period, may account for the higher number
of women with insomnia (Ohayon et al., 2004; Wolkove et al.,
2007).
Interestingly, we observed that older whites had consistently
higher rates of insomnia, OSA, and OSD over the last decade
than older Blacks and older Hispanics. Furthermore, older
Blacks with any type of sleep disturbance appeared to have
lower MR, but higher LOS compared to older Whites. Previous
literature has observed mixed findings regarding the racial
differences in sleep disturbance rates. While some studies have
supported our findings that sleep disturbances appear to be
higher in older Whites than older Blacks (Redline et al., 1997;
Durrence and Lichstein, 2006), other studies have observed that
sleep disturbances appear to be higher in older Blacks than
older Whites (Foley et al., 1999; Ancoli-Israel et al., 2002).
A potential explanation for this inconsistent finding is the
different methodological approaches. The current study uses
clinical diagnostic codes, such as ICD-9-CM, given by a health
provider to estimate sleep disturbance; however, it is unclear
what diagnostic tests were given to assess the symptoms/signs
common to each sleep disturbance. Many of the previous
studies have estimated sleep disturbance, particularly OSA, after
participants have completed clinical evaluation, standardized
questionnaires, an in-lab overnight sleep study, and/or in-home
sleep testing (HST; Salas et al., 2014). Furthermore, many of the
previous studies have actively recruited participants within the
community, while this study is accounting for individuals in the
community that sought medical care. Given Blacks are less likely
than Whites to utilize health care services and/or more likely to
utilize health care resources with severe symptomology (Weech-
Maldonado et al., 2014), our study may be underestimating the
rates of sleep disturbances and the MR associated with sleep
disturbances within older Blacks. However, our finding may
further provides support that sleep disturbances, particularly
in Blacks, may be underdiagnosed in the health care setting
(Kapur et al., 2002; Benca, 2014; Salas et al., 2014). This is
corroborated with findings on income differentials in the rates of
sleep disturbance, whereby for both insomnia and OSA, higher
income individuals had a higher rate, suggesting higher access to
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health care, particularly for OSA which requires a sleep study as
opposed to insomnia which is only assessed through a clinical
diagnosis and patient history.
Primary insurance also appeared to be associated with sleep
disturbances. Older adults with Medicare as their primary
insurance had higher rates across the classes of sleep disturbances
than older adults with a different primary insurance. However,
Medicare beneficiaries with any type of sleep disturbance had
lower MR, lower LOS, and lower TC in comparison with
some of the other primary insurance programs (i.e., Medicaid,
private, and self-pay). Since there are several programs available
under Medicare (e.g., Medicare Advantage program (Weech-
Maldonado et al., 2014), future studies should explore differences
in sleep disturbance rates and hospitalization outcomes across the
Medicare plans.
Similar to previous literature, the current study found that
sleep disturbances are associated with cardiovascular risk factors
(e.g., diabetes, hypertension, and obesity; (Wolkove et al.,
2007; Neikrug and Ancoli-Israel, 2010; Beccuti and Pannain,
2011; Lyons et al., 2015), psychiatric disorders (e.g., depression
and psychoses; Wolkove et al., 2007; Kaufmann et al., 2011),
neurological diagnoses (e.g., AD, dementia, Parkinson’s Disease;
Wolkove et al., 2007; Neikrug and Ancoli-Israel, 2010), cancer
(Neikrug and Ancoli-Israel, 2010), and alcohol consumption
(Wolkove et al., 2007; Neikrug and Ancoli-Israel, 2010). In
addition, our results indicated an increase in the average
number of health conditions over the last decade. Furthermore,
our results highlighted that many co-morbidities (depression,
cardiovascular risk factors, and neurological disorders) steadily
increased over time, which supports a coupling linear trend
between these medical conditions and sleep disturbances. These
findings further support the proposed rationale that the increased
number of health conditions and increased rates of particular
health conditions (e.g., obesity) in the last decade is associated
with the increased rates in sleep disturbances over time
(Kronholm et al., 2008; Pallesen et al., 2014; Ford et al., 2015).
The coupled increase trend in sleep disturbances and medical
conditions may also account for the increasing in-hospital costs.
Hospital characteristics differed across the three classes of
sleep disturbance. Rates for insomnia and OSD were higher in
investor-owned hospitals, hospitals located in rural areas, and
hospitals with smaller bed sizes. In contrast, rates for OSA
were higher in non-profit hospitals, hospitals located in urban
areas, and hospitals with larger bed sizes. There is only limited
research on these differences in hospital characteristics as it
relates to various types of sleep disturbances. It is possible
that neighborhood characteristics (e.g., noise pollution, lighting,
and air quality in neighborhoods near hospital) and individual
characteristics (e.g., proportion of individuals below the poverty
level residing near hospital) may explain these differences.
Further research is warranted to understand how some of these
modifiable factors may reduce the number of individuals with
sleep disturbances, and the subsequent hospital costs associated
with sleep disturbances.
Despite many of study strengths including national
representativeness, large sample size, and availability of extensive
healthcare data that allow for trends analyses, the current study is
not without limitations. First, it relied on administrative database
using ICD-9-CM codes. These codes may not be categorized
based upon the standard diagnosis criteria for sleep disorders,
which may lead to diagnosis misclassification. However, the
AHRQ periodically ensures quality checks with internal and
external validation. Second, discharge abstracts are de-identified,
thus precluding longitudinal analyses. Third, the structure of
NIS limits our ability to detect multiple admissions and/or
discharges from the same condition per patient, including those
with insomnia. In addition, detailed patient data are lacking
such that individual medication regimens and laboratory results
are missing. This precludes examining important covariates we
would otherwise have included. Older adults are likely taking
a number of medications. Previous research has suggested
that this polypharmacy patient profile is even more prominent
amongst older individuals suffering from sleep (Neikrug and
Ancoli-Israel, 2010). Future research is needed to explore how
the relationship between sleep disturbances and hospitalization
characteristics/outcomes is explained by the number and extent
of an individual’s medication regimen. Fourth, NIS is limited
to hospitalized patients with sleep disturbance and thus trend
results may not be similar in the community. Nonetheless,
sleep disturbances are often underdiagnosed and untreated,
particularly within the older adult population (Groth, 2005;
Wolkove et al., 2007; Neikrug and Ancoli-Israel, 2010) and
thus our study’s estimated rates are likely conservative. As with
any retrospective administrative data analysis, there is potential
for bias from missing data; however, it is unlikely that missing
data will have a large effect on the results because of the large
sample size of the current study. Furthermore, we were unable
to compare frequencies of hospitalization between patients with
and without sleep disturbance over pre-set periods of time (e.g.,
a month or a year).
This study observed that while rates of sleep disturbances
are increasing within hospital settings, the relatively low rates
may reflect that many older adults’ sleep disorders remain
underdiagnosed. Since older adults’ sleep disturbances are
associated with an increase in healthcare costs, educational
interventions designed to train healthcare professionals in
recognizing and effectively treating sleep disturbances may assist
in reducing these healthcare expenditures.
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